Clinical Research Directory
Browse clinical research sites, groups, and studies.
Metformin and ACLR Muscle Recovery
Sponsor: University of Utah
Summary
The purpose of this research study is to determine if Metformin taken after anterior cruciate ligament reconstruction (ACLR) surgery can decrease muscle fibrosis, cellular senescence and improve leg strength. ACL injury and surgery increase muscle collagen content and inflammation which slows the recovery of muscle and function and ultimately impacts the quality of life. Individuals enrolled in the study will be randomized to receive metformin (or placebo) for 4 months after surgery. The investigators will measure muscle strength and inflammatory markers in muscle biopsy samples after the intervention period. Investigators will also follow up with participants 8 months later to determine the lasting effects of the intervention.
Official title: Metformin and Muscle Recovery Following ACL Surgery
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-11-01
Completion Date
2032-10-01
Last Updated
2026-07-13
Healthy Volunteers
No
Conditions
Interventions
Metformin
Individuals randomized to the metformin group will take metformin daily (up to 2grams/day) for 4 months following ACLR surgery.
Placebo
Individuals randomized to the placebo will take the same number of pills as the metformin group daily over a 4 month period following ACLR surgery.
Locations (1)
University of Utah
Salt Lake City, Utah, United States